Two-dose emtricitabine/tenofovir alafenamide plus bictegravir prophylaxis protects macaques against SHIV infection

OBJECTIVES: Current prophylaxis options for people at risk for HIV infection include two US FDA-approved daily pre-exposure prophylaxis (PrEP) regimens and guidelines for a 2-1-1 event-driven course specifically for men who have sex with men. Despite this, PrEP use rates remain suboptimal, and addit...

Descripción completa

Detalles Bibliográficos
Autores principales: Bekerman, Elena, Cox, Stephanie, Babusis, Darius, Campigotto, Federico, Das, Moupali, Barouch, Dan H, Cihlar, Tomas, Callebaut, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879143/
https://www.ncbi.nlm.nih.gov/pubmed/33202006
http://dx.doi.org/10.1093/jac/dkaa476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879143/
https://www.ncbi.nlm.nih.gov/pubmed/33202006
http://dx.doi.org/10.1093/jac/dkaa476

Ejemplares similares